Latest: The impact of COVID-19 on diabetic patients – watch on demand
Latest: Oncocyte announces agreement with Thermo Fisher Scientific to expand access to precision...
Latest: Is there a link between SARS-CoV-2 infection and diabetes?
Latest: Enhance your chromatography knowledge with these top trending resources
Latest: Laser-induced breakdown spectroscopy quantification: From fundamental understanding to...
Latest: Legionella testing in drinking water: Approach, evolution and new perspectives
Latest: Akoya Biosciences unveils comprehensive roadmap of innovations at inaugural spatial day...
Is there a link between SARS-CoV-2 infection and diabetes?
Correlating breast cancer subtypes to clinical outcomes and targeted therapeutics in an era of...
StemCultures introduces FGF2 DISC™ Devices for precise control of FGF2 concentration during cell...
New Magnifier Inspection Tool now available from Delta Scientific
A turnkey digital system for precise and consistent pipetting: Your questions answered
The impact of COVID-19 on diabetic patients – watch on demand
A guide to efficient and greener cannabinoid purification
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
Viral cytopathic effects measured in a drug discovery screen
IMMTOX™ 270 benchtop toxicology analyzer: Small, simple and smart
Difficult blocks and reprocessing: What to do when your block won’t section
FreezePoint by ELITechGroup
Cell Analysis Microscopy Equipment
Biophysical Characterization Technology
Virtual Clinical Science Summit
Virtual Cancer & Immunology Research Summit
05 Feb 22 - 09 Feb 22
Analytical Science Summit...
15 Feb 22 - 15 Feb 22
NEW: Infectious Disease &...
01 Mar 22 - 07 Mar 22
PITTCON Conference and Expo...
05 Mar 22 - 09 Mar 22
04 Apr 22 - 08 Apr 22
Abbott has announced the UK launch of NeuroSphere™ Virtual Clinic, a first-of-its-kind technology that allows patients to communicate with physicians, ensure proper settings and functionality, and receive new treatment settings remotely as needed.